scholarly journals Discovery of mitochondrial DNA variants associated with genome-wide blood cell gene expression: a population-based mtDNA sequencing study

2019 ◽  
Vol 28 (8) ◽  
pp. 1381-1391
Author(s):  
Jaakko Laaksonen ◽  
Ilkka Seppälä ◽  
Emma Raitoharju ◽  
Nina Mononen ◽  
Leo-Pekka Lyytikäinen ◽  
...  
Theranostics ◽  
2016 ◽  
Vol 6 (11) ◽  
pp. 1792-1809 ◽  
Author(s):  
Sunil M. Kurian ◽  
Marta Novais ◽  
Thomas Whisenant ◽  
Terri Gelbart ◽  
Joel N. Buxbaum ◽  
...  

2020 ◽  
Vol 31 ◽  
pp. S135-S136
Author(s):  
P. Apostolou ◽  
P. Parsonidis ◽  
A. Iliopoulos ◽  
I. Papasotiriou

2004 ◽  
Vol 93 (2-3) ◽  
pp. 217-226 ◽  
Author(s):  
Lone Frier Bovin ◽  
Klaus Rieneck ◽  
Christopher Workman ◽  
Henrik Nielsen ◽  
Søren Freiesleben Sørensen ◽  
...  

Gene ◽  
2012 ◽  
Vol 497 (2) ◽  
pp. 323-329 ◽  
Author(s):  
Patrizia D'Aquila ◽  
Giuseppina Rose ◽  
Maria Luisa Panno ◽  
Giuseppe Passarino ◽  
Dina Bellizzi

2008 ◽  
Vol 79 (3) ◽  
pp. 477-485 ◽  
Author(s):  
Lars K. Sørensen ◽  
Anne Havemose-Poulsen ◽  
Søren U. Sønder ◽  
Klaus Bendtzen ◽  
Palle Holmstrup

2012 ◽  
Vol 23 (6) ◽  
pp. 616-621 ◽  
Author(s):  
Kevin Dawson ◽  
Ling Zhao ◽  
Yuriko Adkins ◽  
Madhuri Vemuri ◽  
Raymond L. Rodriguez ◽  
...  

Stroke ◽  
2020 ◽  
Vol 51 (Suppl_1) ◽  
Author(s):  
Glen C Jickling ◽  
Joseph Kamtchum ◽  
Gina Sykes ◽  
Yusra Batool ◽  
Stamova Boryana ◽  
...  

Background: Atrial fibrillation (AF) is an important cause of stroke, for which anticoagulation provides substantial benefit. However, not all patients with AF will have a stroke. There remains uncertainty regarding factors that promote thromboembolism and stroke in patients with AF. In this study we examined differences in blood cell gene expression unique to AF in acute stroke to better understand factors important to atrial fibrillation thromboembolism in human stroke. Methods: Gene expression in blood was compared in acute stroke patients with AF to non-AF stroke and to controls without stroke. Blood was collected in PAXgene tubes, and leukocyte/platelet gene expression was measured by Affymetrix microarray. Differentially expressed genes were identified using ANOVA adjusted for age, sex and batch. Results: In the 184 patients studied, 40 were acute strokes with AF, 143 had non-AF acute stroke, and 116 were non-stroke controls. There were 43 genes unique to AF in patients with stroke, and 69 genes associated AF that were shared between AF stroke and controls (FDR<0.05, fold change>|1.5|). Functional analysis indicate acute stroke AF genes are associated with changes in the hematological system including blood cell rheology and leukocyte activation. In contrast non-stroke AF genes are associated cardiac hypertrophy and blood vessel injury. Conclusions: AF has differences in blood cell gene expression in acute stroke that may relate to risk of thromboembolism. Acute stroke patients with AF display changes in blood cell rheology and leukocyte activation; whereas non-stroke AF patients have changes in cardiac hypertrophy and vascular injury. These differences are important to understanding blood cell contribution to thrombus formation and stroke risk in patients with AF. Further study is required to assess the relationship of these gene changes to stroke risk and response to anticoagulation in patients with AF.


Sign in / Sign up

Export Citation Format

Share Document